Announcement on Litigation Involved by the Company and Its Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Litigation Involved by the Company and Its Subsidiary
Filed with SSE · · 4 pages · Chinese
Release
Ningxia Zhongke Biotechnology Co., Ltd. on 6ix
Earlier from Ningxia Zhongke Biotechnology
- Announcement on Results of the Judicial Auction of Shares of the Company Held by Shanghai Zhongneng Enterprise Development (Group) Co., Ltd.
- Announcement on Outward Investment in Establishing Subsidiaries
- Announcement on Expected Loss in Performance for 2025
- Announcement on the Removal of Delisting Risk Warning and Continuation of Other Risk Warnings, along with Temporary Suspension of Trading
- Announcement on Unfreezing of Partial Bank Accounts of Subsidiaries
Later from Ningxia Zhongke Biotechnology
- Announcement on Completion of Industrial and Commercial Change Registration for Registered Capital and Renewal of Business License
- Announcement on New and Accumulative Litigation
- Announcement on Resolutions of the 3rd Meeting of the 10th Board of Directors
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Providing Guarantee for Holding Subsidiary
Follow Ningxia Zhongke Biotechnology into a list and get an email when it puts out news.
Follow Ningxia Zhongke Biotechnology